2 citations
,
January 2025 in “Cutis” This review examined the dermatologic side effects and potential treatments benefits of metformin and GLP-1/GIP agonists in managing skin conditions related to hormonal and immune effects in individuals with type 2 diabetes who are overweight or obese.
February 2025 in “Skin Appendage Disorders” This review discusses the dermatologic side effects and potential therapeutic benefits of GLP-1 receptor agonists, such as facial fat loss and wound healing, emphasizing the need for further research.
August 2024 in “Journal of Dermatology for Physician Assistants” In this review, potential causes of COVID-19 and immunization-induced hair loss are explored, highlighting the need for early treatment and further research to clarify whether stress, viral infection, treatment medications, or nutritional deficiencies are responsible.
March 2026 in “Annals of Plastic Surgery” This review reported potential risks of complications, such as scarring and disease exacerbation, following facial cosmetic procedures in patients with existing dermatologic disorders, emphasizing the need for careful surgical planning to address these challenges.
16 citations
,
January 2021 in “Dermatology and therapy” This review discusses the role of gut microbiota in autoimmune and immune-mediated dermatological conditions like lupus and psoriasis, but reports no new clinical results; the authors emphasize the need for further study into microbial signatures and treatments.